Ana C. Vallor

1.0k citations
13 papers · 797 indexed · h-index 11
Topics
Antifungal resistance and susceptibility (12 papers)Fungal Infections and Studies (8 papers)Nail Diseases and Treatments (2 papers)

In The Last Decade

Ana C. Vallor

13 papers receiving 781 citations

Peers

Ana C. Vallor
Comparison fields: 5 of 80
  • Infectious Diseases 503
  • Epidemiology 476
  • Microbiology 145
  • Molecular Biology 122
  • Cell Biology 95
Replace U. Banerjee with:
U. Banerjee India
M. Miègeville France
Graciela Davel Argentina
Xin Fan China
Frédéric Gabriel France
Keith E. Simmon United States
A W Fothergill United States
R. Aly United States
Pedro García-Martos Spain
A. J. Monteiro Brazil
Ana C. Vallor relative to U. Banerjee India U. Banerjee's profile →
Citations per field
00.5×1.5×1.8×
U. Banerjee · 1×
Citations per year

Countries citing papers authored by Ana C. Vallor

Since Specialization
Citations

This map shows the geographic impact of Ana C. Vallor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana C. Vallor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana C. Vallor more than expected).

Fields of papers citing papers by Ana C. Vallor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana C. Vallor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana C. Vallor. The network helps show where Ana C. Vallor may publish in the future.

Co-authorship network of co-authors of Ana C. Vallor

This figure shows the co-authorship network connecting the top 25 collaborators of Ana C. Vallor. A scholar is included among the top collaborators of Ana C. Vallor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana C. Vallor. Ana C. Vallor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 20
2 61
3 3
4 151
5 1
6 131
7 98
8 27
9 63
10 21
11 45
12 18
13 158

About Ana C. Vallor

Ana C. Vallor is a scholar working on Infectious Diseases, Epidemiology and Microbiology, having authored 13 papers that have together received 797 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (8 papers) and Nail Diseases and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (503 citations), Microbiology (145 citations) and Epidemiology (476 citations). Ana C. Vallor has collaborated with scholars based in United States, New Zealand and Canada. Frequent co-authors include Thomas F. Patterson, Brian L. Wickes, Nathan P. Wiederhold, George R. Thompson, Sharon L. Hillier, May A. Beamer, Stephen E. Hawes, M. Herrera, Jonathan Gelfond and Annette W. Fothergill. Their work appears in journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026